P Pu ur rp po os se e: : Controlling the cerebral and systemic hemodynamic responses to laryngoscopy and tracheal intubation may play a role in determining clinical outcome in pediatric neurosurgical patients. This study compared the effects of remifentanil and fentanyl on cerebral blood flow velocity (CBFV) and hemodynamic profile during laryngoscopy and tracheal intubation in children under sevoflurane anesthesia.M Me et th ho od ds s: : Sixty healthy children aged two to six years undergoing dental surgery under general anesthesia were enrolled. Each child was randomly assigned to receive a remifentanil or fentanyl infusion, at a rate of 0.75, 1.0, or 1.5 µg·kg -1 ·min -1 after induction of anesthesia with 2% sevoflurane. Middle cerebral artery blood flow velocity was measured by transcranial Doppler (TCD) sonography. Once a baseline set of hemodynamic variables and TCD measurements were recorded, the opioid infusion was started. Measurements were taken at two-minute intervals, starting four minutes prior to laryngoscopy until four minutes following naso-tracheal intubation.R Re es su ul lt ts s: : Remifentanil caused a more significant decrease in mean arterial pressure and CBFV prior to tracheal intubation than did fentanyl (P < 0.001). During laryngoscopy and for two minutes following tracheal intubation, CBFV increased in all remifentanil groups (P < 0.05), whereas it remained stable in all fentanyl groups. C Co on nc cl lu us si io on n: : This study suggests that fentanyl was more effective than remifentanil at preventing increases in CBFV during and immediately following laryngoscopy and tracheal intubation in children undergoing sevoflurane anesthesia. Fentanyl also seemed to provide a more stable hemodynamic profile prior to laryngoscopy and tracheal intubation when compared to remifentanil. ARYNGOSCOPY and tracheal intubation may cause significant cerebral and systemic hemodynamic responses, including tachycardia, hypertension and increased intracranial pressure. [1][2][3] Controlling these responses on induction of anesthesia may be an important factor in improving outcome in pediatric neurosurgical patients. Remifentanil is a µ-opioid receptor agonist, rapidly metabolized by nonspecific esterases throughout the blood and tissues. The elimination half-life of remifentanil is less than ten minutes, compared to 219 min for fentanyl. 4-6 It does not accumulate after prolonged continuous infusion and the blood brain equilibration time is rapid. 5,7 Its use is characterized by rapid and complete offset of opioid effects within minutes of infusion discontinuation. 4 These distinctive pharmacokinetic and pharmacodynamic characteristics make remifentanil a potentially attractive opioid for use in pediatric anesthesia. Comparative data assessing cerebral blood flow velocity (CBFV) on induction and tracheal intubation with remifentanil and fentanyl has not been documented in the pediatric population.
ObjectifThe aim of this study was to compare the effects of remifentanil and fentanyl on CBFV and hemodynamic...